<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>AZITRA RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Fri, 01 May 2026 18:52:00 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/azitra%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>AZITRA RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference</title><pubDate>Wed, 07 Jan 2026 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/azitra-inc-to-present-at-biotech-showcase-alongside-the-j-p-morgan-annual-healthcare-conference-15398712</link><description><![CDATA[<p><p id="temp_ReleaseStart" xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">BRANFORD, Conn., <span class="legendSpanClass"><span class="xn-chron">Jan. 7, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American:  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/azitra-inc-to-present-at-biotech-showcase-alongside-the-j-p-morgan-annual-healthcare-conference-15398712</guid></item><item><title>Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American</title><pubDate>Wed, 17 Dec 2025 22:10:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/azitra-receives-notice-of-acceptance-of-the-listing-standards-compliance-plan-from-nyse-american-15366454</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">BRANFORD, Conn., <span class="legendSpanClass"><span class="xn-chron">Dec. 17, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/azitra-receives-notice-of-acceptance-of-the-listing-standards-compliance-plan-from-nyse-american-15366454</guid></item><item><title>Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules</title><pubDate>Mon, 24 Nov 2025 15:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/azitra-inc-announces-pricing-of-1-5-million-private-placement-priced-at-a-premium-to-market-under-nyse-rules-15308840</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">BRANFORD, Conn., <span class="legendSpanClass"><span class="xn-chron">Nov. 24, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/azitra-inc-announces-pricing-of-1-5-million-private-placement-priced-at-a-premium-to-market-under-nyse-rules-15308840</guid></item><item><title>Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates</title><pubDate>Wed, 12 Nov 2025 23:15:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/azitra-inc-announces-q3-2025-results-and-provides-business-updates-15268973</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">BRANFORD, Conn., <span class="legendSpanClass"><span class="xn-chron">Nov. 12, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/azitra-inc-announces-q3-2025-results-and-provides-business-updates-15268973</guid></item><item><title>Azitra, Inc. Addresses False Report Regarding Sale of Securities</title><pubDate>Fri, 07 Nov 2025 12:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/azitra-inc-addresses-false-report-regarding-sale-of-securities-15218990</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">BRANFORD, Conn., <span class="legendSpanClass"><span class="xn-chron">Nov. 7, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/azitra-inc-addresses-false-report-regarding-sale-of-securities-15218990</guid></item></channel></rss>
